Skip to main content
SpringerLink
Log in

Omega-3 Fatty Acids: A Promising Alternative Treatment Approach for Patients with Nonalcoholic Fatty Liver Disease

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci. 2010;55:560–578.

    Article  PubMed  Google Scholar 

  2. Masterton GS, Plevris JN, Hayes PC. Review article: omega-3 fatty acids—a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2010;31:679–692.

    Article  CAS  PubMed  Google Scholar 

  3. Serhan CN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care. 2005;8:115–121.

    Article  CAS  PubMed  Google Scholar 

  4. Capanni M, Calella F, Biagini MR, et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther. 2006;23:1143–1151.

    Article  CAS  PubMed  Google Scholar 

  5. Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis. 2008;40:194–199.

    Article  CAS  PubMed  Google Scholar 

  6. Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413–418.

    Article  CAS  PubMed  Google Scholar 

References

  1. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci. 2010;55:560–578.

    Article  PubMed  Google Scholar 

  2. Capanni M, Calella F, Biagini MR, et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther. 2006;23:1143–1151.

    Article  CAS  PubMed  Google Scholar 

  3. Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis. 2008;40:194–199.

    Article  CAS  PubMed  Google Scholar 

  4. Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413–418.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Turkiye Yuksek Ihtisas Teaching and Research Hospital, 06100, Ankara, Turkey

    Yavuz Beyazit & Murat Kekilli

  2. Department of Gastroenterology, Ankara Numune Education and Research Hospital, Ankara, Turkey

    Tugrul Purnak

Authors
  1. Yavuz Beyazit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tugrul Purnak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murat Kekilli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yavuz Beyazit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beyazit, Y., Purnak, T. & Kekilli, M. Omega-3 Fatty Acids: A Promising Alternative Treatment Approach for Patients with Nonalcoholic Fatty Liver Disease. Dig Dis Sci 55, 2422–2423 (2010). https://doi.org/10.1007/s10620-010-1269-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-010-1269-3

Keywords

Search

Navigation